Viktor Roschke
Fundador en Neuraly, Inc. .
Fortuna: 2 M $ al 31/05/2024
Cargos activos de Viktor Roschke
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Theraly Fibrosis, Inc. operates as a commercial physical research company. The company was founded by Seulki Lee and is headquartered in Germantown, MD. | Director/Miembro de la Junta | - | - |
Secretario Corporativo | - | - | |
Neuraly, Inc.
Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Neuraly, Inc. provides healthcare services. The company was founded by Seulki Lee and Viktor Roschke in 2016 and is headquartered in Gaithersburg, MD. | Director/Miembro de la Junta | 01/01/2016 | - |
Director Técnico/Científico/I+D | 01/01/2016 | - | |
Fundador | 01/01/2016 | - | |
D&D Pharma Tech Co., Ltd.
D&D Pharma Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology D&D Pharma Tech Co., Ltd. engages in drug research and development. It develops medicines for metabolic, degenerative brain, and fibrotic diseases. The company was founded by Seul-Ki Lee, Seong-Mook Im and Kang Choon Lee on November 28, 2014 and is headquartered in Suwon, South Korea. | Director Técnico/Científico/I+D | - | - |
Historial de carrera de Viktor Roschke
Antiguos cargos conocidos de Viktor Roschke.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01/01/2005 | 01/01/2005 |
Teva Biopharmaceuticals USA, Inc.
Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Teva Biopharmaceuticals USA, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD. | Director de Operaciones | - | - |
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Director Técnico/Científico/I+D | 05/07/2012 | - |
Corporate Officer/Principal | 10/09/2010 | - |
Formación de Viktor Roschke.
Novosibirsk State University | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
2 | |
Corea del Sur | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Sectorial
Health Technology | 5 |
Retail Trade | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
Health Technology |
Empresas privadas | 5 |
---|---|
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Retail Trade |
Teva Biopharmaceuticals USA, Inc.
Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Teva Biopharmaceuticals USA, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD. | Health Technology |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Theraly Fibrosis, Inc. operates as a commercial physical research company. The company was founded by Seulki Lee and is headquartered in Germantown, MD. | Health Technology |
Neuraly, Inc.
Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Neuraly, Inc. provides healthcare services. The company was founded by Seulki Lee and Viktor Roschke in 2016 and is headquartered in Gaithersburg, MD. | Commercial Services |
- Bolsa de valores
- Insiders
- Viktor Roschke
- Experiencia